ClinicalTrials.Veeva

Menu

Discriminating Ability of the Cirrus High Definition (HD) Optical Coherence Tomography (OCT) for Glaucoma

Yonsei University logo

Yonsei University

Status

Unknown

Conditions

Glaucoma

Study type

Observational

Funder types

Other

Identifiers

NCT00742378
3-2008-0076-Reproducibility

Details and patient eligibility

About

The Cirrus HD OCT, a new spectral domain optical coherence tomography, has better resolution than the previous OCT. Reproducibility and discriminating ability of the Cirrus HD OCT for glaucoma detection will be studied.

Full description

The Cirrus HD OCT is a newly developed imaging device of the spectral domain optical coherence tomography. Even though its resolution and speed are much better than the previous OCT, its reproducibility and diagnostic power for detecting the glaucomatous defect of retinal nerve fiber layer (RNFL) have not known yet. In the present study, we will review the data of RNFL thickness measurement using the Cirrus HD OCT. After assessing the inter-test variability, the discriminating ability of the Cirrus HD OCT for glaucoma diagnosis will be determined by the ROC curves.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Cooperative patients
  • Repeated OCT data

Exclusion criteria

  • Intraocular surgeries history
  • DM
  • High refractive error ( < -4.00 diopters, or > + 4.00 diopters)
  • Media opacity

Trial design

200 participants in 2 patient groups

C
Description:
Normal controls
G
Description:
Glaucoma

Trial contacts and locations

1

Loading...

Central trial contact

Gong Je Seong, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems